Skip to Content

Newsroom

Health Care

Rep. Nadler Statement Condemning Trump Administration for Refusing to Lift Fetal Tissue Ban for COVID-19 Vaccine Research

| Posted in Press Releases

Today, Congressman Jerrold Nadler (D-NY) issued a statement condemning the Trump Administration's refusal to lift their ban on fetal tissue research as scientists and medical professionals work tirelessly to develop a COVID-19 vaccine and save lives: "Scientists have told Congress again and again that fetal tissue is the gold standard for vaccine research. The ban on this research imposed by the T... Read more »

Combating Coronavirus

| Posted in E-Newsletter

Dear Friends, The number of COVID-19, otherwise known as coronavirus, cases reported on American soil grows every day, including six in New York State, and the White House seems ill-prepared to handle the spread of the virus. I was, therefore, proud to join my colleagues in the House in passing a bipartisan emergency spending package that will provide federal and state authorities with the funds ... Read more »

Rep. Nadler Statement on the Trump Administration’s Inadequate Coronavirus Response

| Posted in Press Releases

Rep. Nadler Statement on the Trump Administration’s Inadequate Coronavirus Response Faced with the threat of a growing global pandemic, Americans deserve better than a White House totally unprepared and demonstrating no urgency to address coronavirus. Over 80,000 people in 37 countries have been infected with coronavirus and more than 2,500 have already died. Today, the Center for Disease Control ... Read more »

Rep. Nadler Statement on S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act

| Posted in Press Releases

Rep. Nadler Statement on S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act On Wednesday, I voted against adoption of S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which the Senate passed on January 16. It is absolutely true that the opioid crisis demands serious and appropriate action to ... Read more »

Rep. Nadler Applauds Ed & Labor Committee Passage of Bipartisan Pregnant Workers Fairness Act

| Posted in Press Releases

Washington, D.C. —Today, the Committee on Education and Labor advanced the Pregnant Workers Fairness Act (H.R. 2694), a bipartisan proposal introduced by Congressman Jerrold Nadler (D-NY) to secure clear and strong protections for pregnant workers. The legislation guarantees pregnant workers’ right to reasonable accommodations–such as extra bathroom breaks, relief from heavy lifting, and other min... Read more »

Rep. Nadler Votes to Pass Lower Drug Costs Now Act, Opposes Funding for Endless Wars

| Posted in E-Newsletter

Dear Friends, This week, while the House Judiciary Committee continued its work on impeachment, I voted on two major pieces of legislation on the House floor. On Thursday, I voted in support of H.R. 3, the Elijah E. Cummings Lower Drug Prices Now Act. This landmark legislation will, for the first time, allow Medicare to negotiate drug prices directly with drug companies to bring down the cost of ... Read more »

Chairman Nadler Statement for the Markup of H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019

| Posted in Press Releases

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019: "H.R. 3991, the 'Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019,' is the second bipartisan measure we a... Read more »

Chairman Nadler Statement for the Markup of H.R. 5133, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019

| Posted in Press Releases

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 5133, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019: "H.R. 5133, the 'Affordable Prescriptions for Patients Through Promoting Competition Act of 2019,' is one of two bipartisan measures that we are considering tod... Read more »

Cicilline, Nadler Introduce Bill to Lower Prescription Drug Costs

| Posted in Press Releases

Washington, D.C. – Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive “product hopping.” The bill is scheduled to be marked up in the Judiciary Comm... Read more »

Nadler Testimony in Support of H.R. 2694, the Pregnant Workers Fairness Act

| Posted in Press Releases

Washington, D.C. — Today, Congressman Jerrold Nadler (D-NY) testified before the House Education and Labor Subcommittee on Civil Rights and Human Services in support of his legislation, the Pregnant Workers Fairness Act, which ensures that pregnant women are not forced out of jobs unnecessarily or denied reasonable job accommodations that would allow them to continue working. The bill guarantees t... Read more »

Back to top